{"id":"W4200357740","doi":"10.1007/s40744-021-00405-w","title":"Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib","year":2021,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Pfizer (Canada)","funders":"Celgene; Gilead Sciences; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Tofacitinib; Discontinuation; Janus kinase inhibitor; Nausea; Adverse effect; Internal medicine; Placebo; Rheumatoid arthritis; Vomiting; Incidence (geometry); Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001279084,0.000231518,0.0006734213,0.0001625197,0.0001132308,0.00001137279,0.00003577477,0.0001318802,0.00006760078],"category_scores_gemma":[0.00004087792,0.0001826221,0.00002703707,0.0002158016,0.000342042,0.0002375252,0.0000171373,0.000192284,0.000001879008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001037644,"about_ca_system_score_gemma":0.0001167006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003170496,"about_ca_topic_score_gemma":0.0004073472,"domain_scores_codex":[0.9985369,0.0001301655,0.000419105,0.0003743501,0.0002230876,0.0003163959],"domain_scores_gemma":[0.9992338,0.00008665741,0.000142453,0.000199172,0.000181107,0.0001567505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001544253,0.0002446247,0.9335933,0.00004573917,0.0001905947,0.0000845808,0.001172821,2.946287e-7,0.0002084666,0.0003709082,0.000001799484,0.06254261],"study_design_scores_gemma":[0.02716625,0.002125111,0.9658456,0.001714058,0.000002496085,0.0007253104,0.0003286581,0.00001735034,0.001145306,0.0006960094,0.00002888357,0.000204903],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805784,0.01856297,0.00001982864,0.0001477945,0.00002403915,0.000563527,0.00002552117,0.00002356358,0.00005437543],"genre_scores_gemma":[0.7783167,0.2212973,0.0002334634,0.00002802813,0.000001896615,0.00004190162,0.00005410214,0.00002097481,0.000005637227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2027344,"threshold_uncertainty_score":0.7447111,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005117525276364914,"score_gpt":0.2183013215595229,"score_spread":0.213183796283158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}